High Q Technologies Inc. is a biotechnology company specializing in the development of quantum-enabled scientific instruments for ultra-high sensitivity biophysical and chemical analysis, particularly through electron paramagnetic resonance (EPR) spectroscopy. Founded in 2013 and based in Waterloo, Ontario, Canada, the company was founded by individuals associated with significant advancements in quantum technology. As of 2025, High Q Technologies has secured a total of $10.2 million in funding. The company is backed by Quantum Valley Investments and Blackberry co-founders Mike Lazaridis and Doug Fregin.
Attribute | Information |
---|---|
Founding Date | 2013 |
Headquarters | Waterloo, Ontario, Canada |
Founders | Not explicitly mentioned in recent sources |
Revenue | Not publicly disclosed |
Profits | Not publicly disclosed |
Key Investors | Quantum Valley Investments, Government of Canada |
Industry | Biotechnology Research |
Number of Employees | 11-50 |
High Q Technologies was founded in 2013 with a mission to harness the power of quantum technology for applications in biotechnology. The company emerged from the intellectual ecosystem fostered by the University of Waterloo's Institute for Quantum Computing. Initially operating as a developer of scientific instruments for biophysical analysis, High Q quickly made a mark by focusing on electron paramagnetic resonance (EPR) spectroscopy, a niche but impactful field in structural biology and drug research. Early collaborations with academic institutions and its strategic location in the Quantum Valley have underscored its commitment to innovation and excellence.
High Q Technologies is recognized for integrating modern microwave quantum optics into EPR spectroscopy, setting a new standard in protein structure determination.
High Q Technologies continues to influence the industry with its advanced quantum-enabled spectroscopic solutions. Its flagship product, the FATHOM™ EPR Spectrometer, plays a crucial role in protein dynamics research, a field critical to future drug discovery and development. The company is positioned as a leader in its niche, leveraging its partnerships and technological edge to maintain competitive advantages and expand its market reach.
High Q Technologies stands out as a pioneering force in the application of quantum technologies in scientific research. Its innovative approach to enhancing electron paramagnetic resonance spectroscopy offers significant potential in drug discovery and structural biology. Looking ahead, High Q is poised for continued impact and expansion, driven by its strategic investments and collaborations, making substantial contributions to both the scientific community and the broader biotechnology industry.